Targeting eicosanoid metabolism to overcome tumor immunosuppression

Project Information

EicoMet

Grant agreement ID: 101123280

DOI

10.3030/101123280

Project closed

EC signature date 15 December 2023

Start date 1 February 2024

End date 31 July 2025

Funded under

• European Research Council (ERC)

Total cost

No data

EU contribution

€ 150 000,00

Coordinated by

VIB VZW
Belgium

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Intellectual Property Rights

Patent (3)

INHIBITION OF PROSTAGLANDIN D2 RECEPTOR 1 AS MEANS FOR TREATING CANCER

Application/Publication number: EP 2024082474
Date: 2024-11-15
Applicant(s): VIB VZW

INHIBITION OF PROSTAGLANDIN D2 RECEPTOR 2 AS MEANS FOR TREATING CANCER

Application/Publication number: EP 2024082481
Date: 2024-11-15
Applicant(s): VIB VZW

HEMATOPOIETIC PROSTAGLANDIN SYNTHASE (HPGDS) INHIBITION FOR TREATING CANCER

Application/Publication number: EP 2024082465
Date: 2024-11-15
Applicant(s): VIB VZW